Ozempic shortages have European countries exploring bans on use of popular drug for weight lossnews2023-11-15T19:18:44+00:00November 15th, 2023|Endpoints News|
CorMedix wins US approval via rarely-used pathway for drug to reduce bloodstream infectionsnews2023-11-15T19:02:17+00:00November 15th, 2023|Endpoints News|
Sanofi hands out community health equity grants in ongoing effort to build trust with marginalized groupsnews2023-11-15T18:49:44+00:00November 15th, 2023|Endpoints News|
A Mark Cuban copy? Cigna’s Express Scripts to offer what it calls another cost-plus pricing modelnews2023-11-15T18:07:26+00:00November 15th, 2023|Endpoints News|
Eli Lilly wins preliminary injunction in Mounjaro compounding casenews2023-11-15T18:07:03+00:00November 15th, 2023|Endpoints News|
Generate:Biomedicines opens the hood on its AI software for making proteinsnews2023-11-15T17:55:36+00:00November 15th, 2023|Endpoints News|
Can post-market evidence generation be streamlined? FDA-commissioned report proposes solutionsnews2023-11-15T17:54:27+00:00November 15th, 2023|Endpoints News|
FDA raises concerns over efficacy of Merck’s potential chronic cough drug ahead of adcommnews2023-11-15T17:41:07+00:00November 15th, 2023|Endpoints News|
Is the worst over? Catalent touts GLP-1 and gene therapy business as it sticks to financial guidancenews2023-11-15T16:31:50+00:00November 15th, 2023|Endpoints News|
Scoop: CellProthera eyes $30M round for PhIII trial of cell therapy for heart attacksnews2023-11-15T16:16:29+00:00November 15th, 2023|Endpoints News|
